Clinical Guides
Pericarditis
A clinically focused, India-adapted clinical guide to recognizing, triaging and managing acute, recurrent, tuberculous and complicated pericardial inflammation while protecting patients from tamponade and inappropriate empirical treatment.
MedNext Academy | 13 min read
Pericarditis
A clinically focused, India-adapted clinical guide to recognizing, triaging and managing acute, recurrent, tuberculous and complicated pericardial inflammation while protecting patients from tamponade and inappropriate empirical treatment.
Summary
Pericarditis is inflammation of the pericardial layers and is a clinical syndrome rather than a single aetiological diagnosis. The common presentation is sharp central or left-sided chest pain that may worsen with inspiration or recumbency and improve on sitting forward, but this pattern is neither universal nor sufficiently specific to exclude acute coronary syndrome, pulmonary embolism or aortic disease. A friction rub, widespread ST-segment elevation with PR depression, and a new or worsening pericardial effusion are other diagnostic features. Myocardial injury may coexist, producing myopericarditis or perimyocarditis and changing monitoring, exercise restriction and prognosis.
Immediate priorities are physiological stability and cause-directed risk assessment. Echocardiography should promptly evaluate effusion, ventricular function and tamponade physiology; it cannot by itself prove inflammation or tuberculosis. C-reactive protein supports inflammatory activity and follow-up, while troponin suggests myocardial involvement but does not grade coronary risk. Cardiac magnetic resonance can demonstrate oedema and pericardial enhancement when the diagnosis or ongoing activity is uncertain. First-line treatment of uncomplicated presumed inflammatory pericarditis usually combines an anti-inflammatory drug with colchicine, plus gastroprotection and activity restriction where appropriate. Tuberculosis, bacterial infection, malignancy, autoimmune disease, renal failure and treatment-related injury require different pathways. This draft is has been reviewed by the MedNext Clinical Team and is not a patient-specific prescription.
How Common Is It?
Reliable incidence estimates vary because mild cases may never reach hospital, coding definitions differ, and many cohorts pre-date routine troponin and cardiac magnetic resonance. Acute pericarditis is nevertheless a familiar cause of non-ischaemic chest pain in emergency and cardiology services. It affects adults of any age, often with a male predominance in idiopathic or post-viral series. Most uncomplicated inflammatory episodes resolve, but a clinically important minority recur, particularly after an incomplete response, premature tapering or corticosteroid exposure. Recurrence is not synonymous with treatment failure: immune-mediated pathways, genetic susceptibility and ongoing inflammation can sustain disease even when no pathogen is identified.
The aetiological distribution is strongly dependent on geography and referral setting. In high-income outpatient cohorts, many cases are labelled idiopathic after targeted evaluation and are presumed viral or immune mediated. In India, tuberculosis must remain an active differential for subacute effusive, effusive-constrictive or constrictive disease, especially with fever, weight loss, night sweats, HIV, exposure or evidence elsewhere. That does not justify empirical antitubercular treatment for every effusion. Tertiary-centre series overrepresent large effusions, malignancy and constriction, whereas community data undercount them. Published European recurrence and complication frequencies therefore cannot simply be presented as Indian population rates. The practical epidemiological lesson is to distinguish low-risk, self-limited patterns from presentations that signal a specific, potentially treatable cause.
Risk Factors
A recent viral syndrome may precede acute inflammatory pericarditis, although routine viral serology rarely establishes causation. Previous pericarditis is the dominant clinical context for recurrence. Autoimmune and autoinflammatory disorders, including systemic lupus erythematosus, rheumatoid disease, adult-onset Still disease and familial recurrent fever syndromes, should be considered when inflammation is recurrent, systemic or poorly responsive. Chronic kidney disease and inadequate dialysis can produce uraemic pericarditis. Myocardial infarction, cardiac surgery, catheter procedures, ablation and chest trauma can trigger post-cardiac injury syndromes. Thoracic radiotherapy, selected drugs and cancer therapies also alter the differential. Immune checkpoint inhibitors can cause pericarditis, myocarditis or an overlapping syndrome; chest symptoms, troponin elevation or conduction change after immunotherapy demand urgent cardio-oncology assessment rather than routine outpatient treatment.
For tuberculous disease, relevant risks include household or occupational exposure, previous tuberculosis, HIV, immunosuppression, undernutrition, diabetes, crowded living conditions and residence in a high-burden community. Malignancy is more likely with a known cancer, unexplained weight loss, haemorrhagic effusion or recurrent large effusion, but absence of cancer history is not reassuring enough to avoid evaluation. Bacterial or purulent pericarditis is uncommon yet dangerous after bloodstream infection, thoracic infection, surgery or immunosuppression. High fever, subacute evolution, large effusion or tamponade, and failure to respond to conventional anti-inflammatory treatment are not causes themselves; they are high-risk features that should prompt admission or structured aetiological investigation.
Diagnosis
Diagnosis integrates the syndrome, haemodynamic state, myocardial involvement and likely cause. Do not allow a characteristic pain description or ECG to terminate assessment for immediately dangerous alternatives.
History
Document onset, site, severity, radiation, pleuritic and positional behaviour, exertional relation and response to analgesia. Ask about dyspnoea, orthopnoea, palpitations, syncope, fever, rigors, viral symptoms, rash, arthralgia, weight loss and night sweats. Record prior episodes, myocardial infarction, cardiac procedures, renal disease, cancer, radiotherapy, autoimmune disease, tuberculosis exposure, HIV risk, pregnancy, medicines and recent immune checkpoint inhibitor therapy. Clarify exercise and occupation because restriction may affect livelihood.
Examination
Measure temperature, pulse, blood pressure, respiratory rate, oxygen saturation and perfusion. Look for raised jugular venous pressure, pulsus paradoxus, muffled sounds, tachycardia, hypotension and shock. A pericardial rub is transient and its absence does not exclude disease. Examine for heart failure, pleural disease, deep-vein thrombosis, focal infection, lymphadenopathy, rash, arthritis, malignancy and constriction signs such as Kussmaul sign, ascites and oedema.
Investigations
Obtain a 12-lead ECG, troponin, CBC, renal and liver profile, electrolytes, CRP or ESR and chest radiograph. Perform transthoracic echocardiography promptly. Test pregnancy where it changes imaging or prescribing. Coronary testing depends on age, risk and presentation. Use cardiac magnetic resonance for uncertain diagnosis, myocardial involvement or persistent inflammation; CT helps define thickening, calcification, masses and extracardiac disease. Pericardiocentesis is urgent for tamponade and diagnostic for suspected bacterial, tuberculous or malignant effusion. Send fluid and, where obtained, tissue for chemistry, cell count, cytology, bacterial studies and appropriately handled tuberculosis NAAT and culture; interpret ADA in context. Pericardial biopsy is selective, not a routine confirmation test.
Differential Diagnosis
Acute coronary syndrome remains the critical mimic. Pericarditic pain, diffuse ECG change and a young age reduce but never abolish coronary probability; regional ST changes, reciprocal depression, dynamic troponin, exertional symptoms or cardiovascular risk should trigger an acute coronary pathway. Pulmonary embolism may cause pleuritic pain, tachycardia, hypoxaemia and troponin elevation. Acute aortic syndrome, pneumothorax, pneumonia, pleurisy, oesophageal rupture and upper abdominal disease are selected according to history and physiology. Costochondritis and reflux are diagnoses of lower acuity only after serious causes have been addressed. Early repolarisation can mimic widespread ST elevation, while myocarditis, Takotsubo syndrome and infarction with non-obstructive coronary arteries can mimic myocardial involvement.
Within pericardial disease, distinguish idiopathic inflammatory disease from tuberculosis, purulent infection, malignancy, uraemia, hypothyroidism, autoimmune serositis, post-infarction or post-procedure inflammation, and drug or radiation injury. In India, subacute constitutional symptoms, lymphocytic exudate, mediastinal nodes, pulmonary or extrapulmonary findings, HIV and constrictive physiology heighten suspicion for tuberculosis, but a positive tuberculin skin test or interferon-gamma release assay does not prove active pericardial disease. Negative fluid smear, culture or NAAT does not reliably exclude a paucibacillary process. Conversely, treating every lymphocytic effusion as tuberculosis can delay lymphoma, metastatic cancer or autoimmune diagnosis. Constrictive pericarditis must be separated from restrictive cardiomyopathy and severe tricuspid or right-sided disease using Doppler physiology, cross-sectional imaging and, occasionally, invasive haemodynamics.
Management
Triage precedes anti-inflammatory therapy. Admit or obtain urgent specialist assessment for high fever, subacute course, large effusion, tamponade, myocardial involvement, immunosuppression, trauma, anticoagulation or failure of initial treatment. Drain tamponade without waiting for aetiological certainty; purulent effusion also requires drainage, cultures and antimicrobial therapy. Stable low-risk presumed inflammatory pericarditis is treated with an aspirin or non-steroidal anti-inflammatory drug chosen around coronary disease, renal function, gastrointestinal risk, pregnancy and interactions, together with colchicine to reduce recurrence. Continue full anti-inflammatory dosing until symptoms and inflammatory activity improve, then taper according to the selected regimen and clinical course. Gastroprotection is usually appropriate.
Corticosteroids are not routine first-line treatment for uncomplicated idiopathic disease because they may favour recurrence and obscure infection. They have a role when a specific immune-mediated indication exists or standard treatment is contraindicated or ineffective, after bacterial and tuberculous infection have been considered. Recurrent, colchicine-resistant, corticosteroid-dependent inflammatory pericarditis may be considered for an interleukin-1 pathway agent in expert care; access and cost in India can be major barriers, and long-term comparative evidence remains incomplete. Treat tuberculosis through current NTEP-aligned care with microbiological sampling and specialist input rather than adding colchicine as a substitute. Persistent constriction may require pericardiectomy at an experienced centre. Restrict strenuous activity during active inflammation and individualise return after clinical remission, normalising biomarkers and resolution of high-risk imaging or myocardial features.
Prescribing Information
Prescribing must be individualised; this section describes safety principles rather than authorising a regimen. Aspirin or an NSAID is selected at anti-inflammatory rather than simple analgesic intensity, with dose and taper taken from a current local cardiology protocol. Check kidney function, blood pressure, peptic-ulcer or bleeding history, anticoagulants, asthma sensitivity, heart failure and pregnancy. Avoid combining NSAIDs and avoid casual continuation after inflammation has resolved. Co-prescribe proton-pump protection when gastrointestinal risk or high-dose treatment warrants it. Colchicine is weight-adjusted in international guidance and generally continued longer than the anti-inflammatory drug. Reduce or avoid it with severe renal or hepatic impairment, review CYP3A4 and P-glycoprotein interactions, and warn about diarrhoea, myopathy and cytopenia. Macrolides, azole antifungals, ciclosporin and some antivirals can create dangerous exposure; concomitant statins may increase muscle toxicity.
Corticosteroid use requires an explicit indication, infection assessment, glucose and blood-pressure planning, bone and gastric risk review, and a slow taper once disease control is achieved. Abrupt or rapid tapering can precipitate recurrence. Interleukin-1 inhibitors require specialist screening for infection, vaccination planning and laboratory surveillance; tuberculosis risk assessment is particularly important in India. Immune checkpoint inhibitor-associated pericardial or myocardial disease is not managed by simply prescribing outpatient colchicine: pause decisions, corticosteroid treatment and rechallenge belong to a cardio-oncology multidisciplinary pathway. Antitubercular therapy and adjunctive steroid decisions must follow current NTEP/ICMR guidance, HIV status, drug susceptibility and interaction review. Rifampicin has extensive interactions, and empirical treatment without a diagnostic plan risks toxicity and missed malignancy.
When to Refer
Refer immediately to an emergency or cardiology service for haemodynamic compromise, suspected tamponade, syncope, significant arrhythmia, acute heart failure, hypoxaemia, persistent severe pain, myocardial injury with dysfunction, or uncertainty about acute coronary syndrome, pulmonary embolism or aortic disease. A patient with raised jugular venous pressure and hypotension should not wait for outpatient echocardiography. Large or rapidly accumulating effusions, bacterial features, trauma, anticoagulation-related bleeding and purulent infection need hospital management. Early referral is also appropriate when fever exceeds the expected mild inflammatory pattern, symptoms evolve subacutely, the patient is immunocompromised, or initial anti-inflammatory treatment fails.
Cardiology follow-up should own repeat symptoms, ECG, CRP, ventricular function and effusion assessment. Recurrent disease, steroid dependence, persistent CRP elevation or cardiac magnetic resonance inflammation merits a pericardial-disease or advanced cardiology opinion before escalating immunomodulation. Suspected tuberculosis requires coordination with an NTEP-linked service and access to microbiology, HIV testing and evaluation for disease elsewhere. Suspected malignancy requires cytology, cross-sectional imaging and oncology input; repeated blind drainage is not definitive care. Constrictive physiology, effusive-constrictive disease or persistent symptoms after antitubercular therapy needs referral to a centre capable of expert echocardiography, CT or CMR, catheter haemodynamics and pericardiectomy. Patients receiving immune checkpoint inhibitors need same-day oncology and cardio-oncology contact for new chest pain, troponin change or rhythm disturbance. Referral should include the treatment timeline, imaging, inflammatory markers and medicines rather than only the label pericarditis.
Red Flags
Cardiac tamponade is a physiological emergency. Alarm features include hypotension, narrow pulse pressure, tachycardia, rising jugular venous pressure, pulsus paradoxus, breathlessness, oliguria, altered mentation and cool peripheries. Classic muffled heart sounds may be absent, and a large effusion can be relatively well tolerated until compensatory mechanisms fail. Echocardiographic chamber collapse and respiratory variation support the diagnosis, but an unstable patient needs urgent drainage based on integrated clinical judgement. Severe ventricular dysfunction, sustained ventricular arrhythmia, high-grade atrioventricular block, syncope or rapidly rising troponin suggests significant myocardial involvement or another diagnosis and requires monitored care.
High fever with rigors, neutrophilia, sepsis, recent thoracic infection or surgery raises concern for purulent pericarditis. Subacute fever, weight loss, night sweats, progressive effusion, HIV or constrictive signs should trigger a tuberculous work-up in India. Haemorrhagic or recurrent large effusion, a mediastinal mass, lymphadenopathy or unexplained systemic decline raises malignancy. New neurological deficit, tearing pain, pulse asymmetry, profound hypoxaemia or unilateral absent breath sounds points away from routine pericarditis toward other emergencies. During therapy, gastrointestinal bleeding, acute kidney injury, severe diarrhoea, muscle pain or weakness, cytopenia and steroid-related infection require urgent medication review. After immune checkpoint inhibitor exposure, conduction disease, weakness suggesting myositis, ptosis, dyspnoea or troponin elevation can herald a high-mortality overlap syndrome. Return of pain during taper should prompt reassessment rather than automatic dose escalation.
Indian Clinical Context
India combines high tuberculosis burden with wide variation in access to echocardiography, cardiac magnetic resonance, pericardial fluid microbiology and cardiothoracic surgery. The ICMR adult pericardial tuberculosis workflow identifies constitutional symptoms, exposure history, echocardiography, pericardial fluid analysis and early recognition of tamponade or constriction as practical anchors. Its March 2022 workflow is India-specific and useful, but it is advisory, compressed to one page and cannot settle every question about NAAT sensitivity, adjunctive corticosteroids, drug resistance or duration. The older INDEX-TB evidence review explicitly graded some steroid recommendations as conditional and based on limited or indirect evidence. Current local NTEP instructions and drug-susceptibility pathways therefore take precedence over remembered examination regimens.
Where advanced imaging is unavailable, careful serial clinical assessment, ECG, CRP, troponin and high-quality echocardiography become more important, not less. Referral networks should identify where urgent image-guided pericardiocentesis, fluid NAAT and culture, cytology, CMR and pericardiectomy can actually be obtained. Cost, travel and lost wages influence adherence to prolonged therapy and follow-up; document a feasible plan and link eligible patients to public TB services. Avoid two opposite errors: labelling every effusion as idiopathic after a normal chest radiograph, and prescribing empirical antitubercular therapy without pursuing tissue, fluid or disease elsewhere when feasible. Screen for HIV with consent and address diabetes, undernutrition and drug interactions. International ESC recommendations should be adapted to Indian epidemiology and availability, while emergency drainage and physiological stabilisation remain universal.
NMC Competency Mapping
This guide supports competency-based learning in cardiovascular history, examination, chest-pain triage, ECG interpretation, pericardial syndromes, heart failure and shock. A learner should be able to elicit positional and pleuritic pain without treating it as pathognomonic; identify a friction rub and tamponade or constriction signs; interpret widespread ST and PR changes in their clinical context; and request troponin, inflammatory markers, echocardiography and cross-sectional imaging for a stated question. The expected performance is not memorising one diagnostic quartet. It is constructing a safe differential that actively excludes acute coronary syndrome, pulmonary embolism and aortic disease while recognising myocardial overlap.
The India-specific component links these skills to extrapulmonary tuberculosis: eliciting contact and constitutional history, recognising effusion and constriction, selecting specimens, understanding that negative microbiology may not exclude disease, and coordinating NTEP care. Prescribing competencies include checking contraindications and interactions for NSAIDs, aspirin, colchicine, corticosteroids and antitubercular medicines rather than recalling an isolated dose. Communication skills include explaining uncertainty, recurrence risk, activity restriction, return precautions and the need for follow-up. At internship level, the learner should initiate monitoring and resuscitation, obtain an urgent echocardiogram, recognise when drainage is required, and refer safely. Pericardiocentesis, biopsy, immunomodulation and pericardiectomy are supervised specialist decisions. Local departments should map these outcomes to the current NMC Medicine competencies and their own entrusted clinical activities rather than inventing a disease-specific code absent from the curriculum.
Key Exam Pearls for NEET PG
Acute pericarditis is classically diagnosed from compatible chest pain, pericardial rub, new widespread ST elevation or PR depression, and new or increasing effusion; no single feature is obligatory. The ECG typically evolves but often does not follow textbook stages. Reciprocal ST depression outside aVR and V1, territorial changes and convincing ischaemic symptoms favour myocardial infarction. Electrical alternans suggests a large swinging-heart effusion but is insensitive. Beck triad is a late and incomplete description of tamponade. Pulsus paradoxus means an inspiratory fall in systolic pressure greater than expected and can occur in other conditions. Echocardiography evaluates haemodynamic impact; pericardial thickness alone does not diagnose constriction. Doppler respiratory variation, septal shift, annular tissue velocities, hepatic-vein flow and clinical context are combined.
Myopericarditis denotes predominant pericardial disease with myocardial injury and preserved ventricular function; perimyocarditis implies predominant myocardial involvement or dysfunction, although usage varies. Colchicine reduces recurrence in inflammatory pericarditis and is generally continued after the NSAID is tapered. Corticosteroids are not reflex first-line treatment for presumed idiopathic disease. Recurrent, inflammatory, colchicine-resistant steroid-dependent disease can respond to IL-1 blockade, but specialist selection and infection screening matter. In India, remember tuberculous effusion, tamponade, effusive-constrictive disease and chronic constriction. Fluid ADA supports but does not prove tuberculosis; tissue or fluid microbiology should be sought when feasible. Tamponade requires urgent drainage. Persistent symptomatic constriction after a suitable reversible-inflammatory window may require pericardiectomy. Restrict exercise during active disease and extend myocardial precautions when troponin, ventricular dysfunction or CMR indicates myocarditis.
Frequently Asked Questions
Does a normal echocardiogram exclude acute pericarditis in a patient with typical pain?
No. Acute pericarditis can occur without a visible effusion, and echocardiography mainly assesses effusion, ventricular function and haemodynamic complications. Diagnosis still integrates symptoms, examination, ECG and inflammatory markers. A normal study also does not remove the need to evaluate acute coronary syndrome, pulmonary embolism or aortic disease when the presentation warrants it.
Should every pericardial effusion in India receive empirical antitubercular treatment?
No. Tuberculosis is an important India-specific differential, particularly in subacute, constitutional, HIV-associated or constrictive presentations, but malignancy, bacterial infection, renal disease and autoimmune causes can look similar. Obtain fluid, tissue or evidence from another site when feasible, coordinate with an NTEP-linked service and document how response and alternative diagnoses will be reviewed.
When can a person resume strenuous exercise after acute pericarditis?
Strenuous activity should stop during active symptoms and inflammation. Return is individualised after clinical remission and appropriate reassessment of CRP, ECG, effusion and ventricular function. Troponin elevation, arrhythmia, ventricular dysfunction or CMR evidence of myocardial involvement requires the more cautious myocarditis pathway, often including rhythm or exercise testing before clearance.
When are interleukin-1 inhibitors considered for recurrent pericarditis?
Specialists may consider them for objectively inflammatory recurrent disease that is colchicine resistant and corticosteroid dependent or otherwise difficult to control. The diagnosis and adherence should be revisited first, and infection including tuberculosis must be assessed. Cost and access are substantial Indian constraints, while pregnancy and long-term sequencing data remain limited.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic